These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Akkermansia muciniphila and Parabacteroides distasonis synergistically protect from colitis by promoting ILC3 in the gut. Gaifem J, Mendes-Frias A, Wolter M, Steimle A, Garzón MJ, Ubeda C, Nobre C, González A, Pinho SS, Cunha C, Carvalho A, Castro AG, Desai MS, Rodrigues F, Silvestre R. mBio; 2024 Apr 10; 15(4):e0007824. PubMed ID: 38470269 [Abstract] [Full Text] [Related]
7. Akkermansia muciniphila improves chronic colitis-induced enteric neuroinflammation in mice. Yilmaz O, Okullu SO, Catakci M, Elmas MA, Pinheiro Y, Arbak S, Demir E, Schaefer KH, Kolgazi M. Neurogastroenterol Motil; 2024 Mar 10; 36(3):e14745. PubMed ID: 38263790 [Abstract] [Full Text] [Related]
8. Recent findings in Akkermansia muciniphila-regulated metabolism and its role in intestinal diseases. Liu MJ, Yang JY, Yan ZH, Hu S, Li JQ, Xu ZX, Jian YP. Clin Nutr; 2022 Oct 10; 41(10):2333-2344. PubMed ID: 36113229 [Abstract] [Full Text] [Related]
9. Akkermansia muciniphila and Gut Immune System: A Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes. Rodrigues VF, Elias-Oliveira J, Pereira ÍS, Pereira JA, Barbosa SC, Machado MSG, Carlos D. Front Immunol; 2022 Oct 10; 13():934695. PubMed ID: 35874661 [Abstract] [Full Text] [Related]
13. Akkermansia muciniphila: A promising probiotic against inflammation and metabolic disorders. Zhao Y, Yang H, Wu P, Yang S, Xue W, Xu B, Zhang S, Tang B, Xu D. Virulence; 2024 Dec 10; 15(1):2375555. PubMed ID: 39192579 [Abstract] [Full Text] [Related]
14. Akkermansia muciniphila and its role in regulating host functions. Derrien M, Belzer C, de Vos WM. Microb Pathog; 2017 May 10; 106():171-181. PubMed ID: 26875998 [Abstract] [Full Text] [Related]
16. Akkermansia muciniphila: a promising target for the therapy of metabolic syndrome and related diseases. Zhou JC, Zhang XW. Chin J Nat Med; 2019 Nov 10; 17(11):835-841. PubMed ID: 31831130 [Abstract] [Full Text] [Related]
17. Alterations of Akkermansia muciniphila in the inflammatory bowel disease patients with washed microbiota transplantation. Zhang T, Li P, Wu X, Lu G, Marcella C, Ji X, Ji G, Zhang F. Appl Microbiol Biotechnol; 2020 Dec 10; 104(23):10203-10215. PubMed ID: 33064186 [Abstract] [Full Text] [Related]
18. Akkermansia muciniphila strain ATCC BAA-835 does not promote short-term intestinal inflammation in gnotobiotic interleukin-10-deficient mice. Ring C, Klopfleisch R, Dahlke K, Basic M, Bleich A, Blaut M. Gut Microbes; 2019 Dec 10; 10(2):188-203. PubMed ID: 30252588 [Abstract] [Full Text] [Related]
19. Alterations in the Abundance and Co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Colonic Mucosa of Inflammatory Bowel Disease Subjects. Lopez-Siles M, Enrich-Capó N, Aldeguer X, Sabat-Mir M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M. Front Cell Infect Microbiol; 2018 Dec 10; 8():281. PubMed ID: 30245977 [Abstract] [Full Text] [Related]
20. Akkermansia muciniphila in infectious disease: A new target for this next-generation probiotic? Keane JM, Cazzaniga M, Gahan CGM. Sci Prog; 2024 Dec 10; 107(1):368504241231159. PubMed ID: 38490164 [Abstract] [Full Text] [Related] Page: [Next] [New Search]